Display Settings:

Format

Send to:

Choose Destination
    Bioorg Med Chem Lett. 2010 Oct 1;20(19):5835-8. Epub 2010 Aug 3.

    Discovery of quinolines as selective glucocorticoid receptor agonists.

    Source

    Medicinal Chemistry Berlin, Lead Generation & Optimization, Bayer Schering Pharma AG, Berlin D-13342, Germany. stefan.jaroch@bayerhealthcare.com

    Abstract

    The dissociated glucocorticoid receptor (GR) agonist ZK 216348 is rendered GR-selective over other nuclear hormone receptors through replacing the methylbenzoxazine with a quinoline moiety. Compounds were shown to be efficacious in cell assays with respect to inflammation endpoints, along with reduced activity in a transactivation assay, hinting at an improved therapeutic window over corticosteroids.

    Copyright © 2010 Elsevier Ltd. All rights reserved.

    PMID:
    20727743
    [PubMed - indexed for MEDLINE]

      Supplemental Content

      Click here to read

      Recent activity

      Your browsing activity is empty.

      Activity recording is turned off.

      Turn recording back on

      See more...
      Write to the Help Desk